Role of cellular and extracellular Par-4 expression in tumor formation and drug sensitivity (2017)
- Authors:
- Autor USP: NAGAI, MARIA APARECIDA - FM
- Unidade: FM
- DOI: 10.1158/1538-7445
- Subjects: APOPTOSE; BIOMARCADORES; EXPRESSÃO GÊNICA
- Language: Inglês
- Imprenta:
- Source:
- Título: Cancer Research
- ISSN: 0008-5472
- Volume/Número/Paginação/Ano: v. 77, n. 6, suppl., abst. A42, 2017
- Conference titles: AACR Special Conference on Translational Control of Cancer: A New Frontier in Cancer Biology and Therapy
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
OLIVEIRA FILHO, Lourival A. e CARLINI, Maria José e NAGAI, Maria Aparecida. Role of cellular and extracellular Par-4 expression in tumor formation and drug sensitivity. Cancer Research. Baltimore: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://doi.org/10.1158/1538-7445. Acesso em: 29 dez. 2025. , 2017 -
APA
Oliveira Filho, L. A., Carlini, M. J., & Nagai, M. A. (2017). Role of cellular and extracellular Par-4 expression in tumor formation and drug sensitivity. Cancer Research. Baltimore: Faculdade de Medicina, Universidade de São Paulo. doi:10.1158/1538-7445 -
NLM
Oliveira Filho LA, Carlini MJ, Nagai MA. Role of cellular and extracellular Par-4 expression in tumor formation and drug sensitivity [Internet]. Cancer Research. 2017 ; 77( 6):[citado 2025 dez. 29 ] Available from: https://doi.org/10.1158/1538-7445 -
Vancouver
Oliveira Filho LA, Carlini MJ, Nagai MA. Role of cellular and extracellular Par-4 expression in tumor formation and drug sensitivity [Internet]. Cancer Research. 2017 ; 77( 6):[citado 2025 dez. 29 ] Available from: https://doi.org/10.1158/1538-7445 - High prevalence of P16 genetic alterations in head and neck tumors
- Alterations of p16 gene in head and neck tumors
- Distinct chrosomal deleted regions defining different subsets head and neck tumors
- Estudo de marcadores de microssatelites para o cromossomo 2 em amostras de tumores de cabeca e pescoco
- Androgen receptor CAG repeat polymorphism in prostate cancer
- Analysis of differentially expressed genes between prostate cancer cell lines regarding androgen receptor status
- In silico analyses identify lncRNAs: WDFY3-AS2, BDNF-AS and AFAP1-AS1 as potential prognostic factors for patients with triple-negative breast tumors
- The transcripts of SFRP1, CEP63 and EIF4G2 genes are frequently downregulated in transitional cel carcinomas of the bladder
- Identification of Differentially Expressed Genes Associated with ERBB2 Over-expression in Human Mammary Cells in Response to Docetaxel
- High prevalence of p16 genetic alterations in head and neck tumours
Informações sobre o DOI: 10.1158/1538-7445 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
